Related Experiment Video
Updated: Jul 15, 2026

Isolation of Valvular Endothelial Cells
Published on: December 29, 2010
Blood Culture-Negative Endocarditis: A Scientific Statement From the American Heart Association: Endorsed by the
Insights
Blood culture-negative endocarditis (BCNE) outcomes are improving due to new diagnostic tools. This statement updates clinicians on managing BCNE, addressing challenges in pathogen identification and treatment.
Area of Science:
- Cardiology
- Infectious Diseases
- Microbiology
Background:
- Blood culture-negative endocarditis (BCNE) historically presents worse outcomes than blood culture-positive endocarditis.
- Challenges in BCNE include difficulties in pathogen-directed antimicrobial therapy and management.
- Advances in diagnostics are transforming the understanding and treatment of BCNE.
Purpose of the Study:
- To provide an updated scientific statement on blood culture-negative endocarditis.
- To highlight recent advances in diagnostic tools for BCNE.
- To assist clinicians in the diagnosis and management of BCNE.
Main Methods:
- Review of current literature and diagnostic advancements in BCNE.
- Multidisciplinary expert panel synthesis of evidence.
- Inclusion of representative clinical scenarios for practical application.
Main Results:
- Novel diagnostic tools are significantly improving the landscape of BCNE.
- These advancements are expected to lead to better patient outcomes.
- The statement provides a comprehensive update on BCNE management strategies.
Conclusions:
- BCNE diagnosis and management are evolving rapidly.
- New technologies offer improved pathogen identification and targeted therapies.
- This statement equips clinicians with current knowledge for optimal BCNE patient care.
Abstract:
Blood culture-negative endocarditis has been associated with worse outcomes when compared with blood culture-positive endocarditis, because pathogen-directed antimicrobial therapy and other management aspects have been difficult to achieve. Novel diagnostic tools, however, have changed the landscape of this syndrome and will likely improve patient outcomes. This American Heart Association scientific statement highlights these advances. The writing group, which represents a multidisciplinary team, provides an update on blood culture-negative endocarditis. Clinical scenarios representative of real-world experiences are included to assist frontline clinicians in the diagnosis and management of this syndrome.
Related Concept Videos
Endocarditis I: Introduction
Endocarditis II: Clinical Features of Infective Endocarditis
Endocarditis III: Medical Management
Endocarditis IV: Nursing Management
Myocarditis II: Clinical Features and Diagnostic Tests
Myocarditis III: Medical Management

